Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple Sclerosis

0
183
Researchers assessed if serum ocrelizumab concentration measured at time of vaccination could predict the humoral response after SARS-CoV-2 vaccination.
[Annals of Neurology]
Abstract